Komori
Changes in Officers4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

(Correction) Partial revision to the "Notice Concerning Changes in Officers of Our Subsidiary, Kyorin Pharmaceutical Group Factory Co., Ltd."

Regarding changes in the officers of the subsidiary, the effective date was changed from 1 May 2026 to 30 April 2026, and the wording was revised from “retirement from office” to “resignation.”

Worth reading
11Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure24 April 2026

Our Subsidiary: キョーリン製薬グループ工場株式会社 — Notice Regarding Changes in Officers

Open the original document
Corrected on the same dayCorrected on the same day as the original document (Calculated from the Original Disclosure Date Indicated in the Document)
This correction2026-04-24
Location of correction (where in the original document)

<Effective date: 1 May 2026>, (1) Directors scheduled to retire from office

Before correction

Effective date: 1 May 2026; Directors scheduled to retire from office / retirement from office

After correction

Effective date: 30 April 2026; Directors scheduled to resign / resignation

ChangesThe effective date was brought forward by 1 day, and “retirement from office” was revised to “resignation.”
Reason for correction

Because some errors were identified.

What was corrected and how
ItemDetails
Disclosure subject to correctionOur Subsidiary: キョーリン製薬グループ工場株式会社 — Notice Regarding Changes in Officers
Original disclosure date24 April 2026
Location of correction<Effective date: 1 May 2026>, (1) Directors scheduled to retire from office
Details of correctionEffective date: 1 May 2026; Directors scheduled to retire from office / retirement from office → Effective date: 30 April 2026; Directors scheduled to resign / resignation
Reason for correctionBecause some errors were identified.
Items this document does not state (1)
Impact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the previously disclosed notice concerning changes in officers contained errors in part.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Correction) Partial revision to the "Notice Concerning Changes in Officers of Our Subsidiary, Kyorin Pharmaceutical Group Factory Co., Ltd." | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori